Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 191

1.

Intermittent Intensive Insulin Therapy for Type 2 Diabetes: Effects on Hypoglycemia, Weight Gain and Quality of Life Over 2 Years.

Emery A, Ye C, Choi H, Kramer CK, Zinman B, Retnakaran R.

Endocr Pract. 2019 Jun 6. doi: 10.4158/EP-2019-0111. [Epub ahead of print]

PMID:
31170361
2.

Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study.

Retnakaran R, Shah BR.

Lancet Diabetes Endocrinol. 2019 May;7(5):378-384. doi: 10.1016/S2213-8587(19)30077-4. Epub 2019 Mar 27.

PMID:
30928459
3.

Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis.

Kramer CK, Campbell S, Retnakaran R.

Diabetologia. 2019 Jun;62(6):905-914. doi: 10.1007/s00125-019-4840-2. Epub 2019 Mar 7. Review.

PMID:
30843102
4.

Stability of insulin and C-peptide measurement with long-term frozen storage of serum: Implications for diabetes research studies.

Retnakaran R, Ye C, Kramer CK.

Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13617. [Epub ahead of print]

PMID:
30565366
5.

Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes.

Nunez Lopez YO, Retnakaran R, Zinman B, Pratley RE, Seyhan AA.

Mol Metab. 2019 Feb;20:63-78. doi: 10.1016/j.molmet.2018.11.003. Epub 2018 Nov 16.

6.

Reply: Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering Drugs.

Kramer CK, Ye C, Retnakaran R.

JACC Heart Fail. 2018 Dec;6(12):1052-1053. doi: 10.1016/j.jchf.2018.10.002. No abstract available.

PMID:
30497650
7.

Gestational diabetes in young women predicts future risk of serious liver disease.

Retnakaran R, Luo J, Shah BR.

Diabetologia. 2019 Feb;62(2):306-310. doi: 10.1007/s00125-018-4775-z. Epub 2018 Nov 13.

PMID:
30426169
8.

Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes.

Mehmood S, Ye C, Connelly PW, Hanley AJ, Zinman B, Retnakaran R.

Cardiovasc Diabetol. 2018 Oct 9;17(1):133. doi: 10.1186/s12933-018-0776-y.

9.

Hepatic fat and glucose tolerance in women with recent gestational diabetes.

Mehmood S, Margolis M, Ye C, Maple-Brown L, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

BMJ Open Diabetes Res Care. 2018 Sep 8;6(1):e000549. doi: 10.1136/bmjdrc-2018-000549. eCollection 2018.

10.

Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.

Kramer CK, Ye C, Campbell S, Retnakaran R.

JACC Heart Fail. 2018 Oct;6(10):823-830. doi: 10.1016/j.jchf.2018.05.021. Epub 2018 Sep 5.

PMID:
30196071
11.

Impact of daily incremental change in environmental temperature on beta cell function and the risk of gestational diabetes in pregnant women.

Retnakaran R, Ye C, Kramer CK, Hanley AJ, Connelly PW, Sermer M, Zinman B.

Diabetologia. 2018 Dec;61(12):2633-2642. doi: 10.1007/s00125-018-4710-3. Epub 2018 Aug 15.

PMID:
30112689
12.

Hyperglycaemia in pregnancy and the effect of diabetes on cardiovascular risk.

Retnakaran R, Sriram U, Wijeyaratne CN, Hod M, Kapur A.

Lancet Diabetes Endocrinol. 2018 Aug;6(8):599. doi: 10.1016/S2213-8587(18)30208-0. No abstract available.

PMID:
30053982
13.

Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes.

Johnston LW, Liu Z, Retnakaran R, Zinman B, Giacca A, Harris SB, Bazinet RP, Hanley AJ.

J Lipid Res. 2018 Sep;59(9):1751-1762. doi: 10.1194/jlr.P084970. Epub 2018 Jul 9.

PMID:
29986954
14.

Changes Over Time in Hepatic Markers Predict Changes in Insulin Sensitivity, β-Cell Function, and Glycemia.

Pinnaduwage L, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2651-2659. doi: 10.1210/jc.2018-00306.

PMID:
29897453
15.

Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy.

Bajaj HS, Ye C, Hanley AJ, Sermer M, Zinman B, Retnakaran R.

Diab Vasc Dis Res. 2018 Sep;15(5):449-457. doi: 10.1177/1479164118779924. Epub 2018 Jun 5.

PMID:
29871496
16.

Early Weight Gain in Pregnancy and Infant Birth Weight-Reply.

Retnakaran R, Wen SW, Tan H.

JAMA Pediatr. 2018 Jun 1;172(6):598-599. doi: 10.1001/jamapediatrics.2018.0410. No abstract available.

PMID:
29710113
17.

Hyperglycemia in pregnancy and its implications for a woman's future risk of cardiovascular disease.

Retnakaran R.

Diabetes Res Clin Pract. 2018 Nov;145:193-199. doi: 10.1016/j.diabres.2018.04.008. Epub 2018 Apr 19. Review.

PMID:
29679623
18.

Effect of short-term intensive insulin therapy on the incretin response in early type 2 diabetes.

Choi H, Kramer CK, Zinman B, W Connelly P, Retnakaran R.

Diabetes Metab. 2019 Apr;45(2):197-200. doi: 10.1016/j.diabet.2018.01.003. Epub 2018 Jan 11.

PMID:
29395808
19.

Two-year trial of intermittent insulin therapy vs metformin for the preservation of β-cell function after initial short-term intensive insulin induction in early type 2 diabetes.

Retnakaran R, Choi H, Ye C, Kramer CK, Zinman B.

Diabetes Obes Metab. 2018 Jun;20(6):1399-1407. doi: 10.1111/dom.13236. Epub 2018 Feb 23.

PMID:
29377408
20.

Supplemental Content

Loading ...
Support Center